Join to View Full Profile
930 Madison AveSte 200Memphis, TN 38103
Phone+1 901-448-6650
Fax+1 901-302-2486
Dr. King is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Benjamin King is an ophthalmologist based in Memphis, TN, with subspecialties in retinal disease and ocular oncology. He completed his medical education at the University of Tennessee Health Science Center College of Medicine in 2013, followed by residencies at the University of Tennessee and University of Iowa Hospitals and Clinics, and fellowships in surgical retina and ocular oncology at the same institutions. His expertise includes macular edema and vitreoretinal disease, with several publications on topics such as retinal artery occlusion and treatments for uveal melanoma and retinoblastoma. He was inducted into the Alpha Omega Alpha Medical Honors Society in 2013.
Education & Training
University of Iowa Health Care Medical CenterResidency, Ophthalmology, 2019 - 2020- University of Iowa Hospitals and ClinicsFellowship, Surgical Retina and Vitreous, 2018 - 2020
University of TennesseeFellowship, Ocular Oncology/Ophthalmic Pathology, 2017 - 2018- University of Tennessee College of MedicineResidency, Ophthalmology, 2014 - 2017
University of Tennessee Health Science Center College of MedicineClass of 2013
Certifications & Licensure
TN State Medical License 2017 - 2028
IA State Medical License 2018 - 2022
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Alpha Omega Alpha AOA Medical Honors Society, 2013
Publications & Presentations
PubMed
- One-Year Tumor Volume Regression Predicts Survival After I-125 Plaque Brachytherapy for Posterior Uveal Melanoma.Nikhil Davé, David J Taylor Gonzalez, Linda A Cernichiaro-Espinosa, Benjamin A King, Matthew W Wilson
American Journal of Ophthalmology. 2026-08-01 - Deep Learning and Experimental Validation of BRCA1-Associated Protein-1 Missense Variant Pathogenicity in Uveal Melanoma.Nikhil Davé, David J Taylor Gonzalez, Mak B Djulbegovic, Linda A Cernichiaro-Espinosa, Benjamin A King
Ophthalmology Science. 2026-07-01 - Ethnic and Socioeconomic Factors Associated with Locally Advanced Retinoblastoma: A Retrospective Study.Edward L Simpson, Benjamin A King, Linda A Cernichiaro-Espinosa, Carlos Rodriguez-Galindo, Chia-Wei Hsu
Ocular Oncology and Pathology. 2026-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
